From Access to Accountability: State Obligations When an Early Medical Abortion Fails

Since the repeal of the Eighth Amendment, Ireland has transformed access to abortion care. Early medical abortion (EMA) is now an established part of reproductive healthcare, with GPs and women’s health practitioners providing a safe, effective and acceptable abortion service throughout the country. Yet, like every medical treatment, EMA is not infallible. In a small number of cases, pregnancy continues despite treatment, requiring further medical intervention.

What happens when a legal abortion does not achieve its intended outcome? More importantly, what obligations does the State have to ensure that a person’s rights remain protected when this occurs?

A failed EMA is more than a clinical complication. It raises fundamental questions about bodily autonomy, dignity, access to healthcare, and the State’s responsibility to ensure reproductive rights are realised in practice, not merely recognised in law. Ireland has made significant progress in improving access to abortion. The next challenge is accountability: ensuring that abortion care remains safe, continuous and rights-based when treatment does not proceed as expected.

When Access Isn’t Enough

EMA involves the administration of medication, typically mifepristone followed by misoprostol, to end a pregnancy without surgery. Recommended by the World Health Organisation (WHO) and reflected in Irish clinical guidance, EMA is recognised as a safe and highly effective method of abortion care.

Nevertheless, no medical treatment is 100 per cent successful. Although uncommon, some pregnancies continue after treatment and require further medical care (see NWIHP National Clinical Practice Guideline).

Under the Health (Regulation of Termination of Pregnancy) Act 2018, abortion on request is available only up to 12 weeks’ gestation. Where an EMA fails and the pregnancy continues beyond this limit, a person may no longer qualify for abortion unless they satisfy the narrow statutory grounds available after 12 weeks. Some have therefore been required to travel abroad for care, while others have been forced to continue an unwanted pregnancy.

This exposes an important gap between legal access and practical access. A person who has lawfully exercised their reproductive choice may lose access to abortion simply because the treatment intended to give effect to that choice was unsuccessful. The question is therefore not whether abortion is legally available, but whether Ireland provides continuous, safe abortion care when complications arise. Once a pregnancy continues after a person has lawfully sought to end it, the issue extends beyond clinical management and into the realm of human rights.

Why a Failed EMA is a Human Rights Issue

International human rights law recognises the right to the highest attainable standard of health. Article 25 of the Universal Declaration of Human Rights and Article12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR) establish healthcare as a fundamental human right, while the WHO defines health as encompassing physical, mental and social well-being, not merely the absence of disease. Reproductive healthcare, including abortion care, forms an integral part of that right.

The right to health does not guarantee perfect medical outcomes. Rather, it requires States to ensure healthcare is available, accessible, acceptable and of good quality. (AAAQ). The WHO Abortion Care Guideline (2024) makes clear that quality abortion care is a continuum requiring timely follow-up, management of complications and person-centred care. Healthcare does not end when medication is prescribed. Continuity of care is itself a defining element of quality healthcare.

Equally important is the right to bodily autonomy, which is exercised when a person makes an informed and voluntary decision about their own body, including the decision to end a pregnancy. When a person commences a lawful EMA, they have already exercised that autonomy. The subsequent failure of the medication does not undo or diminish that autonomous decision. Medicine cannot guarantee a successful outcome, but the State remains responsible for ensuring that the person’s lawful reproductive choice can be realised in practice.

This distinction is critical. A failed EMA is not, by itself, a human rights violation. Medical treatments occasionally fail despite appropriate clinical care. The potential violation arises when the State provides no realistic pathway for completing a lawful abortion after treatment has failed. In those circumstances, the interference with bodily autonomy stems not from the failed medication itself, but from legal or systemic barriers that prevent the person’s autonomous decision from being carried through.

In this sense, bodily autonomy is not exhausted when consent is given for an EMA. Rather, autonomy continues throughout the abortion pathway. Continuous, safe abortion care is therefore the practical mechanism through which bodily autonomy is realised. If the healthcare system cannot provide continued abortion care after a failed EMA, the individual’s lawful decision risks becoming meaningless in practice.

This analysis also reflects an emerging understanding of how care can be violated. Increasingly, international human rights bodies recognise that violence against women may occur not only through abusive treatment, but through the denial, withholding or fragmentation of essential reproductive healthcare. CEDAW General Recommendation No. 35 recognises that violations of women’s sexual and reproductive health rights, including the criminalisation of abortion, the denial or delay of safe abortion and post-abortion care, forced continuation of pregnancy, and the abuse or mistreatment of women seeking reproductive healthcare, constitute forms of gender-based violence, where they cause physical or mental suffering or undermine women’s autonomy. Depending on the circumstances, and the severity of the resulting harm, such violations may also amount to torture or cruel, inhuman or degrading treatment under international human rights law.

Viewed through this lens, the absence of continuous abortion care following a failed EMA is more than a service gap. Where a person who has lawfully sought an abortion is forced to continue an unwanted pregnancy because no pathway exists to complete that abortion, the harm arises not from the failed medication but from the State’s response to that failure. The violence lies in the denial of the follow-up care necessary to give practical effect to a person’s autonomous reproductive decision.

Ireland has made substantial progress through free community-based abortion services, telemedicine and expanding provider availability. However, accountability requires more than making abortion services available in principle. A rights-respecting healthcare system must anticipate that a small number of EMAs will fail and ensure these individuals are not abandoned because of an arbitrary gestational threshold. Where continuous, safe abortion care is unavailable, the State risks failing not only its obligations to respect, protect and fulfil the right to health, but also its duty to exercise due diligence to prevent gender-based violence against women.

From Rights to Accountability: What Must the State Do?

Recognising reproductive rights in law is only the first step. Human rights also require States to implement those rights in practice. International human rights law therefore imposes three interrelated obligations on States: to respect, protect, and fulfil the right to health, including sexual and reproductive health and rights.

To respect these rights, the State must refrain from creating unnecessary legal or practical barriers that interfere with access to reproductive healthcare. Respecting bodily autonomy requires more than permitting an initial abortion. It requires the State to refrain from frustrating a reproductive decision that has already been lawfully exercised. Once an individual has chosen to terminate a pregnancy and commenced an EMA, that autonomous decision should not be defeated solely because treatment has failed and the pregnancy has progressed beyond a statutory gestational limit. Gestational limits that are imposed for regulatory purposes should not leave individuals without a lawful pathway to complete an abortion they have already sought in accordance with the law.

To protect these rights, the State must ensure that healthcare providers are enabled to deliver evidence-based, rights-respecting care. A rights-respecting healthcare system would adopt a human-rights compliant interpretation of the legislation, ensuring continuity of care and access to clear, consistent, accurate and rights-based guidance and information for both clinicians and patients. Unfortunately, the current guidance is unclear and based on a restrictive interpretation of the legislation. NWIHP guidance on the ‘management’ of women who experience a failed EMA suggests that a failed EMA should be treated as a complication. At the same time it asserts, in line with the HSE Model of Care Termination of Pregnancy Services (2023), that it is illegal to perform a repeat abortion procedure in Ireland if an EMA fails and the ongoing pregnancy is detected after 12 weeks gestational age. The failure of the Model of Care to recognise this as continuation of care required for women who have exercised their right to access an abortion and who have experienced a failed EMA is a restrictive interpretation of the 2018 Act, which violates a woman’s right to bodily autonomy and access to safe abortion.

To fulfil these rights, Ireland must create the conditions necessary for the effective enjoyment of reproductive healthcare. This requires accessible services, appropriately trained healthcare professionals, specialist referral pathways where required, effective complaints mechanisms, and adequate resources to ensure services remain available throughout the country. Importantly, it also requires planning for the rare but foreseeable circumstance in which an EMA fails. Human rights do not require medicine to guarantee success, but they do require healthcare systems to respond appropriately when treatment does not go according to plan.

These obligations are reflected not only in Health (Regulation of Termination of Pregnancy) Act 2018, but also in Ireland’s international human rights commitments under Article 8 of the European Convention on Human Rights, the International Covenant on Economic, Social and Cultural Rights (ICESCR), and the Convention on the Elimination of All Forms of Discrimination against Women. Together, these frameworks reinforce a simple but important principle: legal rights are meaningful only when they can be exercised effectively in practice.

The Human Rights Committee’s decision in Mellet v Ireland illustrates this point. In this case, Mellet learnt that her pregnancy involved a fatal foetal impairment and found the prospect of continuing her pregnancy unbearable. She was in a highly vulnerable position and was denied access to an abortion in Ireland in 2011 and forced to travel abroad at her own expense to access abortion care. The Committee affirmed that blocking access to abortion inflicts severe suffering and violates a woman’s core autonomy and human rights under the International Covenant on Civil and Political Rights. In this landmark decision, the Committee declared that Ireland violated Ms Mellet’s right to privacy and subjected her to cruel, inhuman, and degrading treatment. Additionally, they found Ireland guilty of discrimination for failing to provide her with necessary healthcare.

Although Mellet arose in a different legal context, its reasoning remains relevant. Where individuals must travel abroad because the Irish healthcare system cannot provide continuous, safe abortion care after a failed EMA, similar questions arise about whether the State has adequately protected their rights to dignity, autonomy, and health.

Conclusion

The success of abortion law should not be measured solely by whether abortion is legally available. It should be judged by whether the healthcare system enables people to realise the reproductive decisions they have already lawfully made. A failed early medical abortion reminds us that bodily autonomy is exercised when a person decides to end a pregnancy, not only when treatment succeeds. While medicine cannot guarantee perfect outcomes, the State remains responsible for ensuring that its legal and healthcare frameworks provide continuous, safe abortion care when complications arise. Without that continuity, access to abortion risks becoming incomplete, and the exercise of bodily autonomy may be frustrated by barriers beyond the individual’s control.

Where the State does not provide a pathway to continued abortion care following a failed EMA, the issue is no longer simply one of clinical management. It becomes a question of whether Ireland has fulfilled its obligations to respect, protect and fulfil the rights to health, dignity, equality, and bodily autonomy and, in some circumstances, whether the denial of reproductive healthcare may amount to gender-based violence or cruel, inhuman or degrading treatment under international human rights law.

Moving from access to accountability therefore requires more than legislation. It requires recognising that reproductive rights are realised not when abortion becomes lawful, but when every person can exercise those rights safely, continuously, and with dignity, even when care does not proceed as planned.

Allison Martin is a PhD candidate at the School of Law, University College Cork. Allison’s research focuses on the right to health and the right to sexual and reproductive health.


Discover more from Doing Feminist Legal Work

Subscribe to get the latest posts sent to your email.

Discover more from Doing Feminist Legal Work

Subscribe now to keep reading and get access to the full archive.

Continue reading

Doing Feminist Legal Work
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.